News

Artifical intelligence could provide a way forward in treating COVID-19

With new data on therapies emerging almost every week, artificial intelligence could play a key role in the search for COVID-19 treatment options. Prof Dean Ho, Joint Professor at Department of Pharmacology (NUS Medicine), shared his team’s work in optimising the most effective combination of drugs and doses, while A/Prof David Allen, Associate Vice President (Health Innovation and Translation) at NUS, added that it is critical to be flexible in studying treatment options, as everyone interacts with the virus diffenrently.

Artifical intelligence could provide a way forward in treating COVID-19 Read More »

Nature Communications article by Prof. R. Manjunatha Kini: A general approach to protein folding using thermostable exoshells.

PProtein refolding is a complex procedure in bacterial recombinant expression. Aggregation and misfolding are the two challenges that can affect the overall yield and specific activity of the folded proteins. Thermostable exoshells (tES) are being considered as a novel nanoparticle solution for in vitro folding proteins. The tES are 12 nm diameter engineered particles derived from the thermophilic bacteria Archaeoglobus fulgidus with an eight nm aqueous cavity, a volume that can theoretically accommodate any molecules up to a volume of ~270 nm3. The shells, an assembly of 24 subunits contain 4.5 nm pores, which allow for easy permeation of solutes. A single mutation (Phe116 → His) at the three-fold symmetry axis disassembles them at pH 5.8 and assembles at pH 8.0. Twelve highly diverse proteins of interest (POIs) ranging from small toxins to human albumin, a dimeric protein (alkaline phosphatase), a trimeric ion channel (Omp2a), and the tetrameric tumor suppressor, p53 were folded successfully using tES. These proteins differed widely in their size, volume, disulfide linkages, isoelectric point, and multi versus monomeric nature of their functional units. Crude soluble yield (3-fold to >100-fold), functional yield (2-fold to >100-fold), and specific activity (3-fold to >100-fold) were increased for all the proteins tested. The average soluble yield was determined as 6.5 mg of folded protein per 100 mg of tES utilized. The electrostatic charge complementation between the tES interior and the protein substrate appears to be the primary determinant for functional folding.

Nature Communications article by Prof. R. Manjunatha Kini: A general approach to protein folding using thermostable exoshells. Read More »

Nageiswari Parathy appointed as a member of the NUHS Women in Science and Health (WISH) Executive Council

Congratulation to our staff Nageiswari Parathy on being appointed as a member of the NUHS Women in Science and Health (WISH) Executive Council. The NUHS WISH Group works towards advancing women in Science and Healthcare by empowering and supporting them as leaders in education, research, clinical practice and administration.

Nageiswari Parathy appointed as a member of the NUHS Women in Science and Health (WISH) Executive Council Read More »

NUS Medicine cardiovascular research team develops anticoagulant drugs with high anticlotting efficacy and minimal bleeding

A team lead by Research Assistant Professor Koh Cho Yeow from the Cardiovascular Diseases Translational Research Programme at Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and Cardiovascular Research Institute, Associate Professor Mark Chan, from the Department of Medicine, NUS Medicine, who is also the Deputy Director (Clinical Research Matters) from the Cardiovascular Research Institute and National University Heart Centre, as well as, Professor R. Manjunatha Kini from the Department of Biological Sciences and Department of Pharmacology at NUS, developed a series of thrombin inhibitors to be powerful anticoagulants, commonly known as blood thinners or anticlotting medications.

NUS Medicine cardiovascular research team develops anticoagulant drugs with high anticlotting efficacy and minimal bleeding Read More »

A/P LOW Chian Ming featured in Channel News Asia (CNA) programme “Why It Matters”

A/P LOW Chian Ming has been championing the human brain imaging effort through participation in the SYNAPSE (Synchrotron for Neuroscience: an Asia-Pacific Strategic Enterprise) programme. His work has attracted attention from CNA on their “Why It Matters” series.

On 07 Dec 2021, A/P LOW and his team members, Francis TAN and Yoke Ping were featured in the latest episode of “How Do I Cheat Death”. The link to the episode is available here:

A/P LOW Chian Ming featured in Channel News Asia (CNA) programme “Why It Matters” Read More »

32 NUS Scientists Among the World’s Most Highly Cited Researchers

Congratulation to A/P Gautam Sethi, Dr Alan Prem Kumar and Dr Muthu Kumaraswamy Shanmugam (former Senior Research Fellow) on being among the 32 NUS researchers that have been placed among some of the world’s most highly cited researchers, according to the Highly Cited Researchers 2021 List published by data analytics firm Clarivate.

32 NUS Scientists Among the World’s Most Highly Cited Researchers Read More »

Dr. LE Thi Nguyet Minh featured in “Stories of Integration”

Dr. LE was featured in a book titled “Stories of Integration”. This book showcases the journeys of 30 naturalised Singaporeans (Dr. LE is one of them), whose skills and talents brought much benefit to the country. They have adapted to the social and religious fabric of the country, nurtured respect for its culture and traditions, and honoured its history while forging connections within the community.

The book was also featured in CNA, channel 5, channel 8 and several newspapers. A copy of the book is available on Department bookshelf. A video of the book launch is also available on YouTube.

Dr. LE Thi Nguyet Minh featured in “Stories of Integration” Read More »

Winner of Falling Walls Venture 2021

Congratulation to Dr. LE Thi Nguyet Minh on receiving the Falling Walls Venture 2021 Award.

Falling Walls Venture is a global platform for the most promising science start-ups nominated by academic institutions from across the world. The format provides a stage for pioneering founders who have successfully turned science into business, proving how entrepreneurial solutions can help solve today’s most pressing challenges. Every year, emerging companies compete across various industry clusters. The winner of the competition is awarded the title “Science Start-Up Breakthrough of the Year”.

Throughout the year, universities and research institutions from all over the world are called upon to nominate their most innovative science start-up for the competition. The most promising young companies are invited to pitch on the Falling Walls Venture stage. Additionally, they gain access to exclusive networking events and the Falling Walls Community.

Winner of Falling Walls Venture 2021 Read More »

Scroll to Top